Symbols
Aime
Products
News
Market
Portfolio
Brokers
How did Ocugen's revenue and expenses trend in Q4 2024?
5/8/2025 04:31pm
Aime
Ocugen
's revenue for Q4 2024 was $76.4 million, while the R&D expenses were $8.29 million
1
.
OCGN R&D Expenses, Total Revenue
Source:
1.
OCGN Revenue(Q4 2024), R&D Expenses(Q4 2024), SG&A Expenses(Q4 2024)
more
less
Explore
Screener
Best looking stocks that are MACD Golden Cross
Analysis
What is the trend of APOG's stock price?
Learn
What is a smart contract and give examples
Wiki
For diabetes, what foods or drink are good to consume?